TTP4000
TTP4000-101
Phase 1 small_molecule completed
Quick answer
TTP4000 for Alzheimer's Disease is a Phase 1 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- vTv Therapeutics
- Indication
- Alzheimer's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed